Genetics of angiotensin I-converting enzyme

Clinical and Experimental Hypertension

Volumn 19, Issue 5-6, 1997, Pages 659-669

  Costerousse, O ^a   Danilov, S ^a   Alhenc Gelas, F ^a  

^a INSERM   (France)

Author keywords

Angiotensin I converting enzyme; Angiotensins; Diabetic nephropathy; Genetic polymorphism; Kinins; Myocardial infarction

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE;

CONFERENCE PAPER; DIABETIC NEPHROPATHY; DNA POLYMORPHISM; ENZYME RELEASE; GENE EXPRESSION; HEART INFARCTION; HUMAN; HYPERTENSION; INSULIN DEPENDENT DIABETES MELLITUS; MARKER GENE;

EID: 0030818064     PISSN: 10641963     EISSN: None     Source Type: Journal    
DOI: 10.3109/10641969709083177     Document Type: Conference Paper

References (54)

1. Skeggs LT, Kahn JR, Shumway NP. The preparation and function of the of the hypertensin converting enzyme. J Exp Med 1956; 103: 295-9.
2. Erdös E. Angiotensin I- converting enzyme and the changes in our concept through the years. Hypertension (Dallas) 1991; 16: 363-70.
3. Jaspard E, Wei L and Alhenc-Gelas F. Differences in properties and enzymatic specificities between two active sites of angiotensin I converting-enzyme. J. Biol. Chem. 1993; 268: 9496-9503.
4. Azizi M, Rousseau A, Elan E, Guyenne TT, Michelet S, Grognet JM, Lenfant M, Corvol P and Menad J. Acute ACE inhibition increases the plasma level of the natural stem cell regulator N acetyl-seryl-aspartyl-lysyl-proline. J. Clin. Invest. 1996; 97: 588-592.
5. Cushman DW and Ondetti MA. Inhibitors of angiotensin-converting enzyme. Prog. Med. Chem. 1980; 17: 42-104.
6. Marre M, Chatellier G, Leblanc H, Guyenne TT, Menard J and Passa P. Prevention of diabetic nephropathy with enalapril in normotensive diabetics subjects with persistent microalbuminuria. B. M. J. 1988; 297: 1092-1095.
7. Lewis EJ, Hunsiker LG, Bain RP, Rohde RD, for the Collaborative Study Group. The effect of angiotensin converting-enzyme inhibition on diabetic nephropathy. N. Engl. J. Med. 1993; 329: 1456-1462.
8. Maschio G, Alberti D, Janin G, Locatelli F, Mann JFE, Motolese M, Ponticelli C, Ritz E and Ziuchelli P. ACE inhibition in Progressive Renal Insufficiency Study Group: effect of the ACE inhibitor benazepril on the progression of chronic renal insufficiency. N. Engl. J. Med. 1996; 334: 939-945.
9. Costerousse O, Jaspard E and Alhenc-Gelas F. Molecular and genetic aspects of dipeptidylcarboxypeptidase I (the angiotensin I converting-enzyme). Expression in the immune system. Advances in Neuroimmunology 1993; 3: 217-224.
10. Wei L, Alhenc-Gelas F, Soubrier F, Michaud A, Corvol P, Clauser E. Expression and characterization of recombinant human angiotensin I-converting enzyme. J. Biol. Chem. 1991; 266: 5540-5546.
11. Alhenc-Gelas F, Richard J, Courbon D, Warnet J, and Corvol P. Ditribution of plasma angiotensin I-converting enzyme levels in healthy men: Relationship to environmental and hormonal parameters. J. Lab. Clin. Med. 1991; 117: 33-39.
12. Cambien F, Alhenc-Gelas F, Herberth B, Andre J, Rakotovao R, Gonzales M, Allegrini J and Bloch C. Familial resemblance of plasma angiotensin-converting enzyme level: the Nancy Study. Am. J. Hum. Genet. 1988; 43: 774-780.
13. Soubrier F, Alhenc-Gelas F, Hubert C, Allegrini J, John M, Treagear J and Corvol P. Two putative active centers in human angiotensin I converting-enzyme revealed by molecular cloning. Proc. Nat. Acad. Sci. USA 1988; 85: 9386-9390.
14. Lattion AL, Soubrier F, Allegrini J, Hubert C, Corvol P and Alhenc-Gelas F. The testicular transcript of angiotensin I-converting enzyme encodes for the ancestral, non duplicated form of the enzyme. FEBS Lett. 1989; 252: 99-104.
15. Rigat B, Hubert C, Alhenc-Gelas F, Cambien F, Corvol P and Soubrier F. An insertion/deletion polymorphysm in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels. J. Clin. Invest. 1990; 86: 1343-1346.
16. Costerousse O, Allegrini J, Lopez M and Alhenc-Gelas F. Angiotensin I-converting enzyme in human circulating mononuclear cells: genetic polymorphism of expression in T-lymphocytes. Biochem. J. 1993; 290: 33-40.
17. Doria A, Warram JH and Krolewski AS. Genetic predisposition to diabetic nephropathy: evidence for a role of the angiotensin I-converting enzyme gene. Diabetes 1994; 43: 690-695.
18. Rigat B, Hubert C, Corvol P, Soubrier F. PCR detection of the insertion/deletion polymorphism of the human angiotensin converting enzyme gene (DCP1). Nucl Acid Res. 1992; 20:1433.
19. Ludwig E, Corneli P, Anderson J, Marshall HW, Lalouel J-M, Ward RH. Angiotensin-converting enzyme gene polymorphism is associated with myocardial infarction but not with development of coronary stenosis. Circulation 1995; 91: 2120-4.
20. Marre M, Jeunemaître J, Gallois Y, Rodier M, Chatellier G, Sert C, Dusselier L, Kahal Z, Chaillous L, Halimi S, Muller R, Sackmann H, Bauduceau B, Bled F, Passa P and Alhenc-Gelas F, for the Genediab Study Group. Contributions of genetic polymorphisms of the renin angiotensin system to renal complications in insulin dependant diabetes. 1996,Submitted.
21. Cushman D and Cheung M. Concentrations of angiotensin-converting enzyme in tissues of rat. Biochim. Biophys. Acta 1971; 65: 250-261.
22. Alhenc-Gelas F, Weare J, Johnson R and Erdös E. Measurements of human converting enzyme level by direct radioimmunoassay. J. Lab. Clin. Med. 1983; 101: 83-96.
23. Danilov S, Savoie F, Lenoir B, Jeunemaître X, Azizi M, Tarnow L and Alhenc-Gelas F. Development of enzyme linked immunoassays for human angiotensin I-converting enzyme suitable for large studies. J. of Hypert. 1996; 14: 709-717.
24. Cambien F, Poirier O, Lecerf L, Evans A, Cambou JP, Arveiler D, Luc G., Bard J., Ricard S., Tiret L., Amouyel P., Alhenc-Gelas F., and Soubrier F. Deletion polymorphism in the gene for angiotensin-converting enzyme is a potent risk factor for myocardial infarction. Nature 1992; 359: 641-4.
25. Cambien F, Costerousse O, Tiret L, Poirier O, Lecerf L, Gonzalez MF, Evans A, Arveiller D, Cambou JP, Luc G, Rakotovao P, Ducimetiere P, Soubrier F and Alhenc-Gelas F. Plasma level and ACE gene polymorphism of angiotensin-converting enzyme in relation to myocardial infarction. Circulation 1994; 90: 669-76.
26. Tiret L, Kee F, Poirier O, Nicaud V, Lecerf L, Evans A, Cambou JP, Arveiller D., Iuc G., Amouyel P., and Cambien F., Deletion polymorphism in angiotensin-converting enzyme gene associated with parental history of myocardial infarction. Lancet 1993; 341: 991-2.
27. Lindpaintner K, Pfeffer MA, Kreutz R, Stampfer MJ, Grodstein F, Lamotte F, Buring T and Hennelens CI. A prospective eveluation of an angiotensin converting enzyme gene polymorphism and the risk of ischemic heart disease. N. Engl. J. of Med. 1995; 333: 458-459.
28. Samami NJ, Thompson JR, O'Toole L, Channer K and Woods KL. A meta analysis of the association of the deletion allele of the angiotensin converting enzyme gene with myocardial infarction. Circulation 1996; 94: 708-712.
29. Marian AJ, Yu QT, Workman R, Greve G, Roberts R. Angiotensin - converting enzyme polymorphism in hypertrophic cardiomyopathy and sudden cardiac death. Lancet 1993; 342:1073-5.
30. Shunckert H, Hense HW, Holmer SR, Stender M, Perz S, Keil U, Lorell B, and Riegger G. Association between a deletion polymorphism of the angiotensin-converting enzyme gene and left ventricular hypertrophy. N. Engl. J. of Med. 1994; 330: 1634-38.
31. Marre M, Bernadet P, Gallois Y, Savagner F, Guyene TT, Hallab M, Cambien F., Passa P., and Alhenc-Gelas F. Relationship between angiotensin I-converting enzyme gene polymorphism, plasma level and diabetic retinal and renal complications. Diabetes 1994; 43: 384-388.
32. Fogarty DG, Maxwell AP, Hughes A, Nevin NC and Doherthy CC. A deletion polymorphism in the angiotensin-converting enzyme gene is a risk factor for diabetic nephropathy. EDTA proceedings 1994; p 117.
33. Powrie JK, Watts GF, Ingham JN, Taub NA, Talmud PJ and Shaw KM. Role of glycaemic control in development of microalbuminuria in patients with insulin-dependent diabetes. B. M. J. 1994; 309: 1608-1612.
34. Tarnow I, Cambien F, Rossing P, Nielsen FS, Hansen BV, Lecerf L, Poirier O, Danilov S and Parving HH. Lack of relationship between an insertion/deletion polymorphism in the angiotensin I-converting enzyme gene and diabetic nephropathy and proliferative retinopathy in IDDM patients. Diabetes 1995; 44: 489-494.
35. Schmidt S, Schone N, Ritz E and the Diabetic Nephropathy Study Group. Association of ACE gene polymorphism and diabetic nephropathy? Kidney Int. 1995; 47: 1176-1181.
36. Mizuiri S, Hemmi H, Inoue A, Yoshikawa H, Tanegashima M, Fushimi T, Ishigami M, Amagasaki Y, Ohara T, Shimatake H and Hasegawa A. Angiotensin-converting-enzyme polymorphism and development of diabetic nephropathy in non-insulin-dependent diabetes mellitus. Nephron 1995; 70: 455-459.
37. Doi Y, Yoshigumi H, Lino K, Yamamoto M, Ichikawa K, Iwase M and Fujishima M. Association between a polymorphism in the angiotensin-converting-enzyme gene and microavascular complications in Japanese patients with NIDDM. Diabetologia 1996; 39: 97-102.
38. Dudley CRK, Keavney B, Stratton IM, Turner RC and Ratcliffe PJ. U.K. prospective diabetes study XV: relationship of renin-angiotensin system gene polymorphisms with microalbuminuria in NIDDM. Kidney Int. 1995; 48: 1907-1911.
39. Harden PN, Geddes C, Rowe PA, McIlroy JH, Boulton-Jones M, Rodger RSC, Junor BJR, Briggs JD, Connell JMC and Jardine AG. Polymorphisms in angiotensin-converting-enzyme gene and progression og IgA nephropathy. Lancet 1995; 345: 1540-1542.
40. Yoshida H, Mitarai T, Kawamura T, Kitajima T, Miyasaki Y, Nagasawa R, Kawaguchi Y, Kubo H, Ichikawa I and Sakai O. Role of the deletion polymorphism of the angiotensin-converting-enzyme gene in the progression and therapeutic responsiveness of IgA nephropathy. J. Clin. Invest. 1995; 96: 2162-2169.
41. Van Essen GG, Rensma PL, De Zeeuw D, Sluiter WJ, Scheffer H, Apperloo AJ and De Jong PE. Association between angiotensin-converting-enzyme gene polymorphism and failure of renoprotective therapy. Lancet 1996; 347: 94-95.
42. Lachurie ML, Azizi M, Guyene TT, Alhenc-Gelas F and Menard J. Angiotensin-converting-enzyme gene polymorphism has no influence on the circulating renin-angiotensin-aldosterone system or blood pressure in normotensive subjects. Circulation 1995; 91: 2933-2942.
43. Ueda S, Elliott HL, Morton JJ and Connell JM. Enhanced pressor response to angiotensin I in normotensive men with the deletion genotype (DD) for a angiotensin-converting-enzyme. Hypertension 1995; 25: 1266-1269.
44. Jeunemaître X, Lifton RP, Hunt SC, Williams RR and Lalouel JM. Absence of linkage between the angiotensin-converting-enzyme locus and human essential hypertension. Nature Genetics 1992; 1: 72-75.
45. Danser AH, Koning MM, Admiraal PJ, Sassen LM, Derkx FH and Verdouw PD. Production of angiotensin I and II at tissue sites intact pigs. American Journal of Physiology. 1992; 263: H429-H437.
46. Vane GR. Sites of conversion of angiotensin I. Hypertension 1972; Genest J, Koine E, eds Berlin, Springer Verlag, 523-532.
47. Alhenc-Gelas F, Baussant T, Hubert C, Soubrier F and Corvol P. The angiotensin I-converting enzyme in the kidney. J. Hypertens. 1989; 7:S9-S13
48. Roman RJ, Kaldunski ML, Scicli AG and Carretero OA. Influence of kinins and angiotensin II on the regulation of papillary blood flow. Am. J. Physiol. 1988; 255: 801-804.
49. Linz W, Wiemer G and Scholkens BA. Role of kinins in the pathophysiology of myocardial ischemia. In vitro and in vivo studies. Diabetes 1996; 45 (Suppl.) 1: S51-S58.
50. Schunkert H, Dzau VJ, Tang SS, Hirsh AT, Apstein CS and Lorell BH. Increased rat cardiac angiotensin enzyme activity and mRNA expression in pressure overload left ventricular hypertrophy. J. Clin. Invest. 1990; 86: 1913-1920.
51. Johnston CI. Tissue angiotensin converting enzyme in cardiac and vascular hypertrophy, repair, and remodeling. Hypertension. 1994 ; 23 ; 258-268.
52. Challah M, Nicoletti A, Amal JF, Philippe M, Laboulandine I, Allegrini J, Alhenc-Gelas F, Danilov S and Michel JB. Cardiac angiotensin converting enzyme overproduction indicates interstitial activation in renovascular hypertension. Cardiovascular Research 1995; 30: 231-239.
53. Arnal JF, Battle T, Rasetti C, Challah M, Costerousse O, Vicaut E, Michel JB and Alhenc-Gelas F. ACE in three tunicae of rat aorta: expression in smooth muscle and effect of renovascular hypertension. Am. J. Physiol. 1994; 267: H1777-H1784.
54. Vio CP and Alhenc-Gelas F. Differential distribution of angiotensin I converting enzyme in normal and hypertensive rat kidneys. Hypertension 1995; 25: 18.